Q32 Bio Inc.
Price Action
Technical Summary
STAGE 2 UPTRENDQ32 Bio Inc. is in a confirmed Stage 2 uptrend, with price holding above all major moving averages and trend structure remaining intact. Relative strength is leading (RS Rating: 98), indicating clear outperformance against the broad market. Earnings growth of 40% provides fundamental context to the price action. However, price is extended 52% above the 50-day line, increasing the risk of a mean reversion.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $12.40 | +6.21% | ABOVE |
| 50 SMA | $8.68 | +51.66% | ABOVE |
| 100 SMA | $7.02 | +87.53% | ABOVE |
| 150 SMA | $5.77 | +128.09% | ABOVE |
| 200 SMA | $4.95 | +166.19% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is QTTB in an uptrend right now?
QTTB has a trend score of 4/4 based on Minervini's Stage Analysis. Yes, QTTB is in a Stage 2 uptrend with price above all major moving averages (50, 100, 150, 200 SMA) properly stacked.
Is QTTB overbought or oversold?
QTTB's RSI (14) is 56. The stock is in neutral territory, neither overbought nor oversold.
Is QTTB outperforming the market?
QTTB has a Relative Strength (RS) Rating of 98 out of 99. Yes, QTTB is a market leader, outperforming 98% of all stocks over the past 12 months.
Where is QTTB in its 52-week range?
QTTB is trading at $13.17, which is 89% of its 52-week high ($14.85) and 88% above its 52-week low ($1.35).
How volatile is QTTB?
QTTB has a Beta of 0.42 and 52-week volatility of 156%. It's less volatile than the S&P 500 - generally more stable.